Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 113 participants.
Also called NCT01972178
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 113 participants
- Sponsor
- Pronova BioPharma
- Registry
-
NCT01972178
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States
- Registry status
- Terminated
Technical summary
Registry record NCT01972178. Randomized; double masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
- Condition
- Dyslipidemia
- Intervention (Drug)
- PRC-4016
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- Statins
- Lead sponsor
- Pronova BioPharma
Record details
- Record id
cardio:ct-nct01972178- Content hash
540fae9737c6db254ae2e2b75e4b3d10ff4bcbb12294cf663f2fc8847f686616